2016•Endocrinología y NutriciónOpen access

Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study

Manel Puig‐Domingo, Alfonso Soto, Eva Venegas, Ricardo Vilchez, Concepción Blanco, Fernando Cordido, Tomás Lúcas, Mónica Marazuela, Rosa Casany, Guillem Cuatrecasas, Carmen Fajardo, María A. Gálvez, Silvia Maraver-Selfa, Tomás Martín Hernández, Enrique Romero, Miguel Paja, Antonio Miguel Pico, Ignacio Bernabéu, Eugenia Resmini

Open full text 29 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Cabergoline, Pegvisomant, Lanreotide, Medicine, Acromegaly, Cohort, Internal medicine, Retrospective cohort study